BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36598268)

  • 1. Pre-treatment systemic immune-inflammation index as a non-invasive biomarker for predicting clinical outcomes in patients with renal cell carcinoma: a meta-analysis of 20 studies.
    Xu J; Song J; Yang Z; Zhao J; Wang J; Sun C; Zhu X
    Biomarkers; 2023 May; 28(3):249-262. PubMed ID: 36598268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
    Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
    Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Laukhtina E; Pradere B; D'Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Enikeev D; Shariat SF
    Minerva Urol Nephrol; 2022 Jun; 74(3):329-336. PubMed ID: 33769012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
    PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
    Jin M; Yuan S; Yuan Y; Yi L
    Front Oncol; 2021; 11():735803. PubMed ID: 34950577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
    Lolli C; Basso U; Derosa L; Scarpi E; Sava T; Santoni M; Crabb SJ; Massari F; Aieta M; Conteduca V; Maruzzo M; La Russa F; Wheater M; Berardi R; Galli L; De Giorgi U
    Oncotarget; 2016 Aug; 7(34):54564-54571. PubMed ID: 27409344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis.
    Huang Y; Gao Y; Wu Y; Lin H
    Cancer Cell Int; 2020; 20():499. PubMed ID: 33061851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
    Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
    Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model.
    Chrom P; Zolnierek J; Bodnar L; Stec R; Szczylik C
    Int J Clin Oncol; 2019 May; 24(5):526-532. PubMed ID: 30604160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Systemic Immune-Inflammation Index Create a New Perspective for the IMDC Scoring System in Patients with Metastatic Renal Cell Carcinoma?
    Bugdayci Basal F; Karacin C; Bilgetekin I; Oksuzoglu OB
    Urol Int; 2021; 105(7-8):666-673. PubMed ID: 33730725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab.
    De Giorgi U; Procopio G; Giannarelli D; Sabbatini R; Bearz A; Buti S; Basso U; Mitterer M; Ortega C; Bidoli P; Ferraù F; Crinò L; Frassoldati A; Marchetti P; Mini E; Scoppola A; Verusio C; Fornarini G; Cartenì G; Caserta C; Sternberg CN
    Clin Cancer Res; 2019 Jul; 25(13):3839-3846. PubMed ID: 30967420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.
    Yücel KB; Yekedüz E; Karakaya S; Tural D; Ertürk İ; Erol C; Ercelep Ö; Öztaş NŞ; Arslan Ç; Uçar G; Küçükarda A; Sever ÖN; Kılıçkap S; Can O; Yazgan SC; Öksüzoğlu B; Karadurmuş N; Şendur MA; Ürün Y
    Sci Rep; 2022 Oct; 12(1):16559. PubMed ID: 36192500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: a meta-analysis.
    Li X; Lin H; Ouyang R; Yang Y; Peng J
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery].
    Zhang Q; Song HF; Ma BL; Zhang ZN; Zhou CH; Li AL; Liu J; Liang L; Zhu SY; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):149-155. PubMed ID: 36718704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinoma.
    Ozbek E; Besiroglu H; Ozer K; Horsanali MO; Gorgel SN
    Int Urol Nephrol; 2020 Aug; 52(8):1455-1463. PubMed ID: 32172455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
    Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
    Ji Y; Wang H
    World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.